Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries
Matt S. Zinter(UCSF Benioff Children's Hospital), Christopher C. Dvorak(University of California, San Francisco), Saurabh Chhabra(Medical College of Wisconsin), Kirsten M. Williams(National Institutes of Health), Peiman Hematti(UW Health University Hospital), Allistair Abraham(Children's National), Andrew Artz, Amy K. Keating(Boston Children's Hospital), Anil Sapru(University of Southern California), Eva C. Guinan(Dana-Farber Cancer Institute), Staci D. Arnold(Children's Healthcare of Atlanta), Celalettin Üstün(Rush University Medical Center), Richard F. Olsson(AstraZeneca (Netherlands)), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Jeffery J. Auletta(Nationwide Children's Hospital), Marcelo C. Pasquini(Cleveland Clinic), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Caitrin Fretham(National Marrow Donor Program), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Edward A. Copelan(Levine Cancer Institute), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 48
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968